Introduction {#S0001}
============

*Klebsiella pneumoniae* is the most clinically relevant *Klebsiella* species.[@CIT0001] The 2011--2012 Point Prevalence study of the European Centre for Disease Prevention and Control identified *K. pneumoniae* causing 6.8% of hospital-acquired infections (HAIs), which represented the second most frequent *Enterobacteriaceae* after *Escherichia coli*.[@CIT0002] In 2005, almost all European regions were carbapenem-resistant *K. pneumoniae* (CR-*Kp*) free. From 2005 to 2015, CR-*Kp* has emerged in several countries, reaching rates of 40--60%.[@CIT0003] In the TOTEM study, CR-*Kp* was classified as the most critical antimicrobially resistant pathogen and a leading cause of nosocomial infections, mainly in intensive care units (ICUs).[@CIT0004] Furthermore, among 5331 bacteremia cases due to carbapenemase-producing *Enterobacteriaceae*, 96.8% was attributed to *K. pneumoniae*.[@CIT0005] At EU/EEA level, in 2017, 34% of *K. pneumoniae* notified to the European Antimicrobial Resistance Surveillance Network were resistant to at least one of the antimicrobial groups under surveillance, including carbapenems.[@CIT0006]

Carbapenemases production, particularly KPC, represents the most prevalent mechanism for carbapenems resistance in *K. pneumoniae*,[@CIT0005],[@CIT0007] but the carbapenemases GES, NDM, IMP, VIM, and OXA-48 can also be involved.[@CIT0008] *K. pneumoniae* carrying the gene *bla*~KPC~ are endemic in Italy since nearly 90% of CR-*Kp* are KPC producers, followed by *bla*~VIM~ (9.2%) and *bla*~OXA-48~ (1.3%).[@CIT0003],[@CIT0009],[@CIT0010] In *K. pneumoniae*, extended spectrum beta-lactamases (ESBLs) have been also detected, being involved in oximino-cephalosporin resistance and able to hydrolyze beta-lactams.[@CIT0011] During 1990--2000, *K. pneumoniae* has become the major ESBL-carrying pathogen in hospital outbreaks, mostly carrying *bla*~TEM~ and *bla*~SHV~.[@CIT0012]

The increasing prevalence of multidrug-resistant (MDR) Gram-negative bacteria has led to re-introduction of colistin, especially for infections sustained by *K. pneumoniae*.[@CIT0004] Nevertheless, in the last years, colistin resistance has also emerged in CR*-Kp* with rates as high as 36%.[@CIT0003],[@CIT0013],[@CIT0014] In this case, resistance is due to structural modifications of lipopolysaccharide (LPS) that is the target for colistin. Resistance could be attributed to *mgr*B inactivation by down-regulation of the Pmr system involved in LPS modification, neutralizing the negative charge and decreasing colistin binding,[@CIT0015],[@CIT0016] or through plasmid-mediated *mcr* (*mcr*-1,2,3,4,5,6,7,8 variants).[@CIT0017]--[@CIT0023]

Management of CR-*Kp* infections is associated with long hospitalizations and poor outcomes[@CIT0001],[@CIT0014] and complicated by MDR emergence, which severely limits antimicrobial treatment options.[@CIT0014] Since *K. pneumoniae* is among the most frequent agents in nosocomial settings,[@CIT0008] identification of outbreaks due to MDR strains is crucial. In this scenario, molecular typing enabling strains comparison is required for detecting epidemics and tracking infection sources and factors involved in the transmission.[@CIT0024] For *K. pneumoniae* molecular characterization, the foremost approaches rely on pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST) systems.[@CIT0025]

In this study, clinical *K. pneumoniae* isolated in the main hospital in Molise Region, central Italy, were characterized to evaluate MDR patterns, genetic differences and relationships, and prevalence of carbapenem resistance determinants, as well as to elucidate the mechanisms involved in colistin resistance.

Materials and Methods {#S0002}
=====================

*K. pneumoniae* Cultures and DNA Extraction {#S0002-S2001}
-------------------------------------------

Twenty-six *K. pneumoniae* cultures isolated within the "*Alert Organism*" surveillance system during 2014--2017 were collected from the main hospital for acute care in Molise Region, central Italy. The hospital at the time of the study had a total of 336 beds, 320 for acute care and 16 for ICU.[@CIT0026] Additionally, there were 19 total wards: ten of medicine and surgery specialties, four of pediatrics and two of ICU specialties, followed by single wards of gynecology/obstetrics, geriatrics, psychiatry, rehabilitation, and mixed specialties.

The selection criteria for the tested strains were non-replicates cultures, and a KPC phenotype evaluated with the Matrix-Assisted Laser Desorption Ionization-Time-Of-Flight Mass Spectrometry (MALDI-TOF) assay, as reported by the hospital laboratory. *K. pneumoniae* cultures were mostly recovered from aspirated bronchial (n=9, 35.0%) samples, urine (n=6, 23%), rectal swab (n=4, 15.4%), and blood cultures (n=3, 11.5%) ([Table 1](#T0001){ref-type="table"}). Fifteen (57.7%) isolates were from patients admitted to ICU: 60% male, overall mean age 73±12.6 years (median 78.5, range 44--89 years). Clinical specimens were cultured and purified on McConkey agar plates (Biolife, Milan, Italy) incubated at 37°C overnight. DNA was extracted using Maxwell^®^ 16 Cell DNA Purification Kit (Promega, Milan, Italy).Table 1Patient\'s Clinical Data and Characteristics of Analyzed StrainsStrainIsolation dateAgeGenderSampleWardClinical Data and Risk FactorsKP316/08/201485MBlood cultureMedicineInfection/sepsis (fever)KP418/08/201479MBronchial aspirateICUInfection Invasive proceduresKP530/10/201463MUrineICUUrinary tract infectionKP620/10/201440FUrineUrologyUrinary tract infectionKP719/11/201475MProsthetic liquidOrthopaedicInfection/sepsisKP817/11/201484MBronchial aspirateICUPulmonary infection Invasive proceduresKP909/12/201476MBronchial aspirateICUPulmonary infection Invasive proceduresKP1014/12/201470MBlood cultureInfectious diseaseInfection/sepsisKP1115/12/201463MBlood cultureUrologyInfection/sepsisKP1205/01/201585FUrine cultureICUUrinary tract infectionKP1405/01/201574MBronchial aspirateICUInfection/sepsis Invasive proceduresKP1812/01/201575FBronchial aspirateICUPulmonary infection Invasive proceduresKP1912/01/201581MBronchial aspirateICUPulmonary infectionKP2525/01/201656MUlcer swabDiabetologyDiabetic foot with amputationKP2701/02/201660MBronchial aspirateICUUrinary tract infectionKP2829/02/201659MUrine cultureICUUrinary tract infection Invasive proceduresKP2902/03/201671FRectal swabICUColonizationKP3111/09/201650MRectal swabICUColonizationKP3220/02/201782FUrine cultureInfectious diseaseUrinary tract infectionKP3406/03/201756MBronchial aspirateICUPulmonary infectionKP3603/04/201778FBronchial aspirateICUUrinary tract infection Invasive proceduresKP3909/11/201758FStentNephrologyNot availableKP4006/11/201759FUrineNephrologyUrinary tract infection Invasive proceduresKP4107/11/201778MCystOrthopaedicNot availableKP4207/11/201787MRectal swabICUColonizationKP4319/12/201757MRectal swabICUColonization

Antimicrobial Susceptibility Testing {#S0002-S2002}
------------------------------------

The susceptibility to nineteen antimicrobials was evaluated by the hospital Microbiology laboratory using BD Phoenix™ Automated Microbiology System (Becton Dickinson Diagnostic Systems, Sparks, United States). The minimum inhibitory concentrations (MICs) were calculated for imipenem, ertapenem and meropenem (carbapenems); ampicillin, amoxicillin-clavulanate, piperacillin and piperacillin-tazobactam; ceftazidime, cefuroxime and cefotaxime; amikacin and gentamicin; ciprofloxacin and levofloxacin; fosfomycin, trimethoprim-sulfamethoxazole, tigecycline, and tobramycin. The microdilution method was used for colistin (polymyxin) MIC determination. Results were interpreted according to the European Committee on Antimicrobial Susceptibility Testing breakpoints.[@CIT0027]

Detection of Resistance-Associated Genes {#S0002-S2003}
----------------------------------------

Genes involved in carbapenems resistance were detected through single PCR assays, targeting *bla*~KPC~, *bla*~GES~, *bla*~IMP~, *bla*~VIM~, *bla*~OXA-48~ and *bla*~NDM-1~ genes.[@CIT0028],[@CIT0029] Amplifications were performed in 25 μL volume with 2 μL DNA template, 1X PCR Master Mix (Promega Corporation) and 1 µM of each primer. Target genes were amplified at specific conditions: 94°C 2 mins; 35 cycles: 94°C 1 min, 45°C (*bla*~IMP~)/52°C (*bla*~KPC~)/54°C (*bla*~GES~)/56°C (*bla*~VIM/OXA-48~)/60°C (*bla*~NDM-1~) 40 sec, 72°C 1 min; 72°C 5 mins. PCR amplicons were electrophoretically separated (1.0--1.5% m/v concentration, 1X TAE buffer at 100 V for 1 hr), including 100 bp DNA ladder (Promega). Positive and negative control were used in each batch of reactions.

*K. pneumoniae* isolates were also screened for *bla*~SHV~, *bla*~TEM~, and *bla*~CTX-M~ genes by Multiplex PCR assays, using previously described oligonucleotides and specific cycling conditions.[@CIT0011] The amplified products were resolved by agarose gel electrophoresis (1.5% m/v concentration, 1X TAE buffer at 100 V for 1 hr) including a 100 bp DNA ladder (Promega) and controls in each batch of reactions.

Molecular Analysis of Colistin Resistance {#S0002-S2004}
-----------------------------------------

The colistin-resistant (col-R) isolates were screened by singleplex PCRs for the presence of *mcr*-1,[@CIT0017] *mcr*-2,[@CIT0018] *mcr*-3,[@CIT0019] *mcr*-4,[@CIT0020] *mcr*-5,[@CIT0021] *mcr*-6,[@CIT0022] *mcr*-7,[@CIT0023] *mcr*-7.1[@CIT0023] and *mcr*-8.[@CIT0022] Amplifications were performed in 25 μL volume using 2 μL DNA, 1X PCR master mix (Promega Corporation) and primers at 1 µM. Amplicons were characterized after agarose gel electrophoresis (1.5% m/v concentration, 1X TAE buffer at 100 V for 1 hr) including a 100 bp DNA ladder (Promega).

PCR analysis of *mgr*B was performed using mgrB_Ext_F and mgrB_Ext_R primers targeting *mgr*B coding sequence and some flanking regions, as previously reported.[@CIT0013] Amplifications were carried out in 25 μL volume using 5 μL DNA template, 1X PCR master mix (Promega) and oligonucleotides at 2 µM.

Colistin-sensitive (col-S) strains were used as a negative control carrying wild-type *mgr*B. PCR products were characterised using agarose gel electrophoresis (1.5% m/v concentration, 1X TAE buffer at 100 V for 1 hr) with a 100 bp DNA ladder (Promega). Amplicons longer than the expected molecular weight (253 bp) suggested the presence of an Insertion Sequence (*IS*), and were analyzed by Sanger sequencing (Eurofins Genomics, Germany GmbH, Ebersberg, Germany), including col-S strains as control. Sequences were analyzed with Basic Local Alignment Search Tool (BLAST; blast.ncbi.nlm.nih.gov/Blast.cgi) and processed with BioEdit v7.0.5.

The nucleotide sequences of wild-type *mgr*B in KP25 and KP42 isolates (GenBank Accession numbers MN389772 and MN389773, respectively), as well as those of col-R strains without *IS*s (KP5, KP6, KP7, KP9, KP10, KP28, KP31, KP34, KP36, KP39, KP40, KP41 and KP43) were deposited at BankIt/GenBank (Accession numbers: MN389775, MN389774, MN389776, MN389777, MN389778, MN389779, MN389780, MN389781, MN389782, MN389783, MN389784, MN389785, and MN389786, respectively).

To translate DNA sequences, EMBOSS Transeq ([<https://www.ebi.ac.uk/Tools/st/emboss>]{.ul}) tool was used. The amino acid sequences were analyzed with Protein Variation Effect Analyzer (PROVEAN, [<http://provean.jcvi.org/index.php>]{.ul}) allowing prediction by algorithm of the functional impact for all classes of sequence variations.[@CIT0030] The change in the alignment score was considered as a measure of change in similarity caused by variation and thus to protein functionality.

Molecular Typing by PFGE and MLST {#S0002-S2005}
---------------------------------

For PFGE, bacterial DNA was digested with *Xba*I (Fermentas, Milan, Italy) according to PulseNet protocol using conditions of pulse times from 5 to 40 sec over 24 hrs at 6.0V/cm and at 14°C.[@CIT0031] Pulsotypes were analyzed through BioNumerics software (Applied Maths, Sint-Martens-Latem, Belgium), and dendrograms were generated using Dice coefficient and unweighted pair group method with arithmetic mean (UPGMA).[@CIT0009] The similarity band patterns interpretation was performed according to Tenover criteria,[@CIT0024],[@CIT0032] setting 85% and 95% similarity *cut-off* for identifying similar restriction patterns and clusters, respectively. A validated MLST scheme was used,[@CIT0033] and PCR products were sequenced by Sanger method (Eurofins Genomics) to identify allelic profiles and assign the Sequence Type (ST). The allelic combination was analysed on Pasteur platform ([<http://bigsdb.pasteur.fr/perl/bigsdb/bigsdb.pl?db=pubmlst_klebsiella_seqdef_public>]{.ul}).

Results {#S0003}
=======

Antimicrobial Resistance Profiles in *K. pneumoniae* Cultures {#S0003-S2001}
-------------------------------------------------------------

*K. pneumoniae* cultures showed a multi-carbapenem-resistant phenotype, with all resistant to ertapenem, 22 (84%) to meropenem, and 20 (77%) to imipenem. Twenty isolates were resistant to all carbapenems tested. In addition, nineteen (73%) strains were col-R. No isolates were susceptible to ampicillin, amoxicillin-clavulanate, ceftazidime, ciprofloxacin, cefotaxime, cefuroxime, levofloxacin, piperacillin and piperacillin-tazobactam. Moreover, 81% (n=21) isolates showed resistance to tobramycin, while 16 (62%) were resistant to trimethoprim, 16 (61.5%) to amikacin, 8 (31%) to tigecycline, 5 to gentamicin, and 2 to fosfomycin.

Prevalence of Resistance-Associated Genes {#S0003-S2002}
-----------------------------------------

All *K. pneumoniae* harbored *bla*~KPC~, and 69.2% (n=18) were *bla*~VIM~ positive. A high proportion of isolates also carried ESBLs. The *bla*~SHV~ and *bla*~TEM~ were found in 96.2% (n=25) and 88.4% (n=23), respectively, and 84.6% (n=22) harbored both genes. The *bla*~CTX-M~ was only found in two strains. None of the strains carried *bla*~GES~, *bla*~NDM-1~ or *bla*~OXA-48~.

Prevalence of *mcr* Variants and *mgr*B Analysis {#S0003-S2003}
------------------------------------------------

None of the 19 col-R isolates showed plasmid *mcr*-1,2,3,4,5,6,7,8 variants. Colistin resistance was also investigated through *mgr*B analysis, and the initial evaluation using agarose gel analysis, considering that the expected amplicon for wild-type *mgr*B has a 253 bp size.[@CIT0013] PCR products were sequenced to identify *IS* or mutations involved in colistin resistance.

Amplicons longer than the expected size were observed in six (31.6%) out of the 19 col-R isolates, and sequencing confirmed the presence of transposon. The most common insertion element detected in five cultures belonged to *IS*5-like family (1056 bp), while *IS*Kpn14 element was found in KP11 ([Figure 2](#F0002){ref-type="fig"}). Furthermore, KP8, KP12, KP14, KP18 and KP19 isolates with *IS*5-like elements were all grouped in the PFGE cluster VIII.

In col-R strains with 253 bp amplicon, an identical deletion ∆g19 causing frameshift mutation and premature MgrB termination was found in KP9 and KP10 (n=2, 10.5%) isolates; missense mutations t95→g translated into V32G were found in 42.1% (n=8; KP5, KP31, KP34, KP36, KP40, KP41 and KP43) isolates; missense mutations c62→a translated as T21N occurred in KP28, as well as missense mutation g60→a translated into W20Stop was found in KP31 ([Figures 3](#F0003){ref-type="fig"} and [4](#F0004){ref-type="fig"}). After open reading frame identification, sequence analysis with PROVEAN was reported in [Table 2](#T0002){ref-type="table"}.Table 2PROVEAN Analysis of the Single Amminoacid Change of MgrB ProteinStrainVariantDescriptionPROVEANPredictionscore(cut off= −2.5)KP5V32GValine in position 32 is mutated in Glycine−7DeleteriousKP7KP31KP34KP36KP40KP41KP43KP28T21NThreonine in position 21 is mutated in Asparagine−3.23Deleterious[^1]

*K. pneumoniae* Molecular Epidemiology {#S0003-S2004}
--------------------------------------

PFGE revealed 12 clusters at 85% *cut-off* similarity ([Figure 1](#F0001){ref-type="fig"}): cluster VIII was the most common, grouping 9 (34.6%) isolates, followed by cluster V with three isolates, and clusters III, IV, and VI, each including two cultures. Dendrogram analysis at 95% similarity revealed 18 pulsotypes (PTs), with PT12 as the prevalent (n=4 isolates, 15.3%), followed by PT1, 3, 8 and PT10, each associated with two strains. PFGE discriminatory power was of 96%, as calculated by Simpson's Index of Diversity.[@CIT0034]Figure 1PFGE dendrogram (Dice coefficient) and MLST results for 26 clinical *K. pneumoniae* isolates.**Note:** The new ST is highlighted in blue.**Abbreviation:** ST, Sequence Type.Figure 2Antimicrobials resistance phenotypes and antimicrobial resistance genes profiles for 26 *K. pneumoniae* isolates.**Abbreviations:** col-S, colistin-sensitive; Δg19, deletion of guanine in position 19; V32G, Valine in position 32 is mutated in Glycine; T21N, Threonine in position 21 is mutated in Asparagine; W20stop, Tryptophan is mutated in *stop* codon; unknown, no mutation in *mgr*B gene.Figure 3Alignment of FASTA *mgr*B sequence in col-R *K. pneumoniae* without *IS*s compared with wild-type (WT) sequences in col-S isolates.**Notes:** WT strains in blue; mutation highlighted in red.Figure 4FASTA alignment of MgrB amino acid sequence in col-R *K. pneumoniae* without *IS*s compared with wild-type (WT) sequence of col-S strains.**Notes:** WT MgrB in col-S strains in light blue; non-functional MgrB without *IS*s in col-R strains in green; truncated MgrB in col-R strains in yellow.

Three STs were identified (discriminatory power=0.61): the ST512 as the most common (n=13, 50%), followed by ST101 (n=10), and ST307 (n=2). It was not possible to define ST for KP10. ST512 was the most frequently detected during 2014--2015 (84.6%), while ST101 was the predominant during 2016--2017 (61.5%).

Discussion {#S0004}
==========

The rapid spread of antibiotics resistance is nowadays a major concern causing untreatable infections in humans. A rising of MDR rate would lead to 10 million people dying every year by 2050, which exceeds the 8.2 million estimated deaths due to cancer.[@CIT0035]

This study describes the AMR profiles and molecular epidemiological insights concerning colistin-resistant CR-*Kp* isolated during 2014--2017. *K. pneumoniae* were most commonly isolated from patients aged ≥60 years who were treated in the ICU, where invasive procedures with devices at risk of generating biofilms formation play a crucial role in the occurrence of CR-*Kp*.[@CIT0009],[@CIT0036],[@CIT0037]

Twenty-one antimicrobial susceptibility patterns were found, underlining high inter-strain diversity. All cultures had an MDR pattern, with high percentages of carbapenem (76.9%) and colistin resistance (73%). Conversely, 92% of cultures were susceptible to fosfomycin, which has been recently evaluated for treating extensively drug-resistant (XDR) pathogens, although resistance associated to *fos*A gene is emerging and can be transferred between *Enterobacteriaceae*.[@CIT0038]

The increased application of colistin therapy for infections due to MDR Gram-negative bacteria has contributed to the spread of transmissible resistance, and may speed up the progression from XDR to Pan-drug Resistant (PDR) *Enterobacteriaceae*.[@CIT0004],[@CIT0014],[@CIT0039] In our study, prevalence of col-R *K. pneumoniae* was higher than that reported in other Italian studies, ranging between 36.1% and 50%.[@CIT0009],[@CIT0040]--[@CIT0042]

Results regarding ESBLs presence are in line with other studies, where plasmid-acquired *bla*~TEM~ and *bla*~SHV~ were frequently associated with *Klebsiella* spp. infections.[@CIT0043],[@CIT0044] Conversely, *bla*~CTX-M~ enzymes have become the most prevalent in *E. coli*, with potential to spread beyond the hospital environment in other species.[@CIT0045] The identification of ESBL-producing *Klebsiella* in hospital settings should be followed by infection control interventions, with reinforcement of hand hygiene of primary importance, followed by compliance with guidelines on antibiotic stewardship, and removal of contaminated devices.[@CIT0046]

Concerning carbapenemases encoding genes, *bla*~VIM~ and *bla*~KPC~ genes were detected in 70% and 100% isolates, respectively, which is consistent with the endemic KPC circulation reported in Italy.[@CIT0005] Globally, the most worrying scenario is the increasing spread and dissemination of KPC-producing *K. pneumoniae* of clonal complex CC258 and CC512 being responsible for several outbreaks, unlike VIM carbapenemase, which is currently not widely diffused in Italy.[@CIT0008],[@CIT0047] Furthermore, *K. pneumoniae* producing NDM-1 or OXA-48 were not detected, similarly to IMP and GES, according to national data reporting sporadic cases.[@CIT0045]

The increasing occurrence of col-R strains is considered a global concern. In Italy, a retrospective study (from January 2010 to June 2014) reported a threefold increase of colistin-resistance rate in KPC-producing *K. pneumoniae* in blood isolates, and 51% mortality at 30 days due to bloodstream infections.[@CIT0048]

In our study, *mcr-*1,2,3,4,5,6,7,8 were not detected in col-R strains, which is consistent with previous reports,[@CIT0042] being more frequently detected in *E. coli* than in *K. pneumoniae*.[@CIT0049] Approximately 95% of col-R isolates carried alterations in *mgrB*, which is likely to be responsible for the colistin-resistant phenotypes. Inactivation of *mgr*B throughout *IS*s especially by *IS*5-like and *IS*Kpn14 elements was detected in six out of 19 col-R strains. These mechanisms were reported elsewhere,[@CIT0013],[@CIT0016] and *IS*s transfer within genomes and plasmids has been considered a common driver of diversity and acquisition of antibiotic resistance.[@CIT0050] Furthermore, it has been reported that plasmids transfer between strains within the gut is a potential mechanism of indirect acquisition of colistin resistance.[@CIT0051] As assessed in vitro,*IS* interrupting *mgr*B and conferring colistin resistance was initially located on a plasmid.[@CIT0052]

In three isolates, a truncated MgrB due to one single nucleotide deletion causing frameshift mutation and premature termination was found, as reported elsewhere.[@CIT0053] In addition, nine isolates had a non-functional MgrB due to one amino acid change (V32G, T21N and W20Stop), as observed in other studies.[@CIT0001],[@CIT0009],[@CIT0053] Hence, colistin resistance was linked to alterations in *mgr*B because complementation studies with a wild-type *mgr*B demonstrated that susceptibility to colistin can be successfully restored.[@CIT0053] In our study, col-R KP6 showed a wild-type *mgr*B, suggesting mutations in other colistin-resistance-related genes within Pmr signaling system or by alternative mechanism(s).

The presence of identical *mgr*B alterations in isolates from the same ward and assigned to the same ST and PFGE profile supports the clonal expansion and cross-transmission in hospital setting.[@CIT0053]

PFGE revealed high level of strains diversity, and results from MLST indicated the circulation of ST512, ST101 and ST307. In the tested isolates, ST512, a single-locus variant of ST258, the most frequently detected clone responsible for KPC global spread,[@CIT0054] was the most common that is consistent with studies elsewhere in Italy.[@CIT0009],[@CIT0037],[@CIT0039] For KP10 strain, the ST was not assigned, being found a monoallelic variant of ST307 (4-1-1-52-1-1-7 instead of 4-1-2-52-1-1-7); thus, further analyses are needed to confirm the novel ST. Interestingly, MLST revealed that ST512 was the most frequently detected in 2014--2015, while ST101 prevailed during 2016--2017, suggesting a changed circulation in the latest years in our hospital. Remarkably, PFGE cluster VIII grouped 77% of col-R cultures, four of which isolated from patients within the ICU as indistinguishable pulsotypes, all carried transposons in *mgr*B and were isolated during Christmas season holidays (December 2014--January 2015). In particular, the cluster VIII included the cultures KP8 (isolation data 17/11/14), KP12 and KP14 (isolation data 12/1/14), and KP18 (isolation data 5/1/15) ([Table 1](#T0001){ref-type="table"}), belonging to a group of strains isolated during an outbreak in the ICU ward, which was likely related to a low level of compliance to standard hygiene procedures because of reduced personnel availability, and underlined the likelihood of bacterial persistence in the hospital environment.[@CIT0010]

The discriminatory abilities of PFGE and MLST were compared by the number of unique STs and number of clusters identified. PFGE showed good discriminatory power, and it is still considered a reference method for the epidemiological investigations of infectious diseases, including nosocomial outbreaks.[@CIT0055] PFGE, generating genome-wide DNA fingerprints with rare-cutter restriction enzymes, is also a cost-effective method; nevertheless, it is labor-intensive and may lack comparability between laboratories due to operator errors in identifying bands particularly when shifted or weak on PFGE gel image analysis. In our study, MLST was less discriminating than PFGE, as found elsewhere.[@CIT0024] Anyway, MLST is considered the most suitable genotyping method for strains comparison, further providing data within laboratories, and appropriate for global and long term or evolutionary studies rather than local epidemiology.[@CIT0055]

Conclusions {#S0005}
===========

To our knowledge, this is the first study concerning colistin and carbapenems resistance characteristics in clinical *K. pneumoniae* isolates from the Molise Region, central Italy. Although focusing on topic investigated elsewhere, our findings can be useful to better understand the most significant concerns on hospital infections by *K. pneumoniae* at a local level, and can support the molecular epidemiology data related to CR-*Kp* both nationally and internationally, hence contributing to complete the framework of the epidemiology of this microorganism.

This study confirms that CR-*Kp* infections are most commonly detected in ICU patients due to their critical conditions and invasive procedures like catheterization or tracheostomy. In our setting, the KPC enzyme remains the predominant carbapenemase in *K. pneumoniae*, followed by VIM. The highest prevalence of KPC was linked with ST512 prevalence, although a switching towards ST101 circulation was detected. A high level of colistin resistance was found, more than the rate reported in other studies, likely due to an overuse of colistin in our hospital setting, and it is associated with acquisition of insertion elements or accumulation of deleterious mutations in the *mgr*B gene. Further investigations are warranted to clarify the entire role of Pmr signaling system in col-R strains.

In conclusion, infections with carbapenem-resistant organisms, particularly when KPC-producing, are widely distributed, and antimicrobial treatments selected should be critically evaluated, since an optimal therapy is not yet defined.[@CIT0056] In light of the lack of novel antimicrobial agents for the treatment of difficult healthcare infections, the implementation of proper prevention strategies and adequate staffing is essential to control the spread of MDR *K. pneumoniae*.[@CIT0026] Moreover, the routine application of molecular analyses for rapid and accurate detection of determinants and mutations conferring resistance is crucial to reduce and control the burden of MDR bacterial infections[@CIT0040] and to guide best-choice therapy for better patient outcomes, as well as to elucidate epidemiology and dynamics of dissemination in the hospital environment.

Certainly, while, on one hand, not all the infections are associated with modifiable factors, evidences suggest that the spectrum of situations in which currently it is possible to intervene is broader than in the past. Furthermore, triggering and modifiable factors are mostly due to inadequate healthcare practices, particularly to the failure in applying standard and specific precautions for infectious diseases to avoid unnecessary procedures, the inappropriate use of antibiotics, and the lack of human and technological resources to be committed in the care and prevention.
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[^1]: **Notes:** Variants and their description are reported in the second and third columns, respectively. PROVEAN score is a measure of the change in protein structure: if the score is equal or below to the predefined threshold (cut off =−2.5), the variant is predicted to have a "deleterious" effect; if above, the variant is predicted to have a "neutral" effect.[@CIT0027] In the latter column, there is a prediction of the mutation effect on the protein functionality.
